Fabry Disease Clinical Trials

A listing of Fabry Disease medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

California

Los Angeles California 90048

A clinical trial seeking patients for a research study for the treatment of Fabry Disease

Orange California 92868

A clinical research study of migalastat HCl for the treatment of Fabry Disease

Sacramento California 95825

Patients are needed to participate in a clinical research study to evaluate Fabry Disease

Florida

University of South Florida- South Tampa Center For Advanced Healthcare
Tampa Florida 33606

Rare disease registries for certain lysosomal storage disorders, including, but not limited to, Fabry, Gaucher, MPS I, and Pompe diseases (each, a Registry)

View More ▼

Tampa Florida 33606

Patients are needed to participate in a clinical research study to evaluate Fabry Disease

Massachusetts

Boston Massachusetts 02115

Patients are needed to participate in a clinical research study to evaluate Fabry Disease

Cambridge Massachusetts

Patients are needed to participate in a clinical research study evaluating agalsidase beta for the treatment of Fabry Disease

Springfield Massachusetts 01107

A clinical research study of migalastat HCl for the treatment of Fabry Disease

Michigan

UPDATED

Grand Rapids Michigan 49525

Patients are needed to participate in a clinical research study of PRX-102 and Agalsidase beta to evaluate Fabry Disease

Montana

Helena Montana 59601

Patients are needed to participate in a clinical research study to evaluate Fabry Disease

New Jersey

Morristown New Jersey 07960

Patients are needed to participate in a clinical research study to evaluate Fabry Disease

Paterson New Jersey 07503

Patients are needed to participate in a clinical research study to evaluate Fabry Disease

Ohio

UPDATED

Cincinnati Ohio 45229

Patients are needed to participate in a clinical research study of PRX-102 and Agalsidase beta to evaluate Fabry Disease

Cleveland Ohio 44195

Patients are needed to participate in a clinical research study to evaluate Fabry Disease

Columbus Ohio 43212

A clinical trial seeking patients for a research study for the treatment of Fabry Disease

Columbus Ohio 43210

Patients are needed to participate in a clinical research study to evaluate Fabry Disease

Dublin Ohio 43017

Patients are needed to participate in a clinical research study to evaluate Fabry Disease

Texas

Baylor Scott & White Research Institute
Dallas Texas 75204

A Phase 1/2, Open Label, Dose Ranging Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Exploratory Efficacy Parameters of PRX-102 Administered by Intravenous Infusion Every 2 Weeks for 12 Weeks to Adult Fabry Patients

View More ▼

UPDATED

Dallas Texas 75226

Patients are needed to participate in a clinical research study of PRX-102 and Agalsidase beta to evaluate Fabry Disease

Virginia

UPDATED

Fairfax Virginia 22030

Patients are needed to participate in a clinical research study of PRX-102 and Agalsidase beta to evaluate Fabry Disease

Algeria

Oran 31000

A clinical trial to evaluate treatments for patients with Fabry Disease, Anderson-Fabry Disease, Lysosomal Storage Diseases or Alpha-Galactosidase A Deficiency

Australia

Parkville Victoria 3050

A clinical research study of migalastat HCl for the treatment of Fabry Disease

Parkville 3050

Patients are needed to participate in a clinical research study to evaluate Fabry Disease

Austria

Graz A-8036

A clinical trial to evaluate treatments using No intervention for patients with Fabry Disease or Cerebrovascular Accident

Salzburg A-5020

A clinical research study for the treatment of Fabry's Disease

Wien A-1090

A clinical research study for the treatment of Fabry's Disease

Brazil

Sao Paulo 14048-900

A clinical trial to evaluate treatments for patients with Fabry Disease, Anderson-Fabry Disease, Lysosomal Storage Diseases or Alpha-Galactosidase A Deficiency

Sao Paulo 04024-002

Patients are needed to participate in a clinical research study to evaluate Fabry Disease

Canada

Calgary Alberta

A Phase 1 clinical study for patients with Fabry Disease

Calgary Alberta T3B 6A8

A Phase 3 clinical study for patients with Fabry Disease

Edmonton Alberta T6G 2H7

A Phase 3 clinical study for patients with Fabry Disease

Halifax Nova Scotia B3H 1V8

A Phase 3 clinical study for patients with Fabry Disease

Halifax Nova Scotia B3K 6R8

A Phase 3 clinical study for patients with Fabry Disease

View More ▼

Kingston Ontario K7L 3J6

A Phase 3 clinical study for patients with Fabry Disease

London Ontario N6C 2V5

A Phase 3 clinical study for patients with Fabry Disease

Montreal Quebec H4J 1C5

A Phase 3 clinical study for patients with Fabry Disease

Sherbrooke Quebec J1H 5N4

A Phase 3 clinical study for patients with Fabry Disease

Toronto Ontario M5T 3L9

A Phase 3 clinical study for patients with Fabry Disease

Vancouver British Columbia V5Z 1M9

A Phase 3 clinical study for patients with Fabry Disease

Winnipeg Manitoba R3A 1S1

A Phase 3 clinical study for patients with Fabry Disease

Chile

Coquimbo 1710228

Patients are needed to participate in a clinical research study to evaluate Fabry Disease

Iquique

Patients are needed to participate in a clinical research study to evaluate Fabry Disease

Iquique

Patients are needed to participate in a clinical research study to evaluate Fabry Disease

Santiago

Patients are needed to participate in a clinical research study to evaluate Fabry Disease

Santiago

Patients are needed to participate in a clinical research study to evaluate Fabry Disease

Croatia

Zagreb 10000

A clinical trial to evaluate treatments using No intervention for patients with Fabry Disease or Cerebrovascular Accident

France

Bordeaux 33076

Patients are needed to participate in a clinical research study to evaluate Fabry Disease

Lille 59037

Patients are needed to participate in a clinical research study to evaluate Fabry Disease

Lille 59037

Patients are needed to participate in a clinical research study to evaluate Fabry Disease

LIMOGES Cedex 87042

Patients are needed to participate in a clinical research study to evaluate Fabry Disease